281 related articles for article (PubMed ID: 28726720)
1. TGF-β-Dependent Growth Arrest and Cell Migration in Benign and Malignant Breast Epithelial Cells Are Antagonistically Controlled by Rac1 and Rac1b.
Melzer C; von der Ohe J; Hass R; Ungefroren H
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726720
[TBL] [Abstract][Full Text] [Related]
2. RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.
Zinn R; Otterbein H; Lehnert H; Ungefroren H
Cells; 2019 Dec; 8(12):. PubMed ID: 31817229
[TBL] [Abstract][Full Text] [Related]
3. Rac1b negatively regulates TGF-β1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling.
Ungefroren H; Sebens S; Giehl K; Helm O; Groth S; Fändrich F; Röcken C; Sipos B; Lehnert H; Gieseler F
Oncotarget; 2014 Jan; 5(1):277-90. PubMed ID: 24378395
[TBL] [Abstract][Full Text] [Related]
4. The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma.
Melzer C; Hass R; von der Ohe J; Lehnert H; Ungefroren H
Cell Commun Signal; 2017 May; 15(1):19. PubMed ID: 28499439
[TBL] [Abstract][Full Text] [Related]
5. The role of small GTPases of the Rho/Rac family in TGF-β-induced EMT and cell motility in cancer.
Ungefroren H; Witte D; Lehnert H
Dev Dyn; 2018 Mar; 247(3):451-461. PubMed ID: 28390160
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of TGF-β1-induced MKK6-p38 and MEK-ERK signalling and epithelial-mesenchymal transition by Rac1b.
Witte D; Otterbein H; Förster M; Giehl K; Zeiser R; Lehnert H; Ungefroren H
Sci Rep; 2017 Dec; 7(1):17313. PubMed ID: 29229918
[TBL] [Abstract][Full Text] [Related]
7. The Ratio of RAC1B to RAC1 Expression in Breast Cancer Cell Lines as a Determinant of Epithelial/Mesenchymal Differentiation and Migratory Potential.
Eiden C; Ungefroren H
Cells; 2021 Feb; 10(2):. PubMed ID: 33567745
[TBL] [Abstract][Full Text] [Related]
8. Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.
Mandel K; Seidl D; Rades D; Lehnert H; Gieseler F; Hass R; Ungefroren H
PLoS One; 2013; 8(2):e56591. PubMed ID: 23457587
[TBL] [Abstract][Full Text] [Related]
9. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL
J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465
[TBL] [Abstract][Full Text] [Related]
11. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1-induced cell migration in pancreatic carcinoma cells is RAC1 and NOX4-dependent and requires RAC1 and NOX4-dependent activation of p38 MAPK.
Witte D; Bartscht T; Kaufmann R; Pries R; Settmacher U; Lehnert H; Ungefroren H
Oncol Rep; 2017 Dec; 38(6):3693-3701. PubMed ID: 29039574
[TBL] [Abstract][Full Text] [Related]
13. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression.
Koo BH; Kim Y; Je Cho Y; Kim DS
Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313
[TBL] [Abstract][Full Text] [Related]
15. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
16. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
17. Different signaling and functionality of Rac1 and Rac1b in the progression of lung adenocarcinoma.
Seiz JR; Klinke J; Scharlibbe L; Lohfink D; Heipel M; Ungefroren H; Giehl K; Menke A
Biol Chem; 2020 Mar; 401(4):517-531. PubMed ID: 31811797
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
[TBL] [Abstract][Full Text] [Related]
19. Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase.
Groth S; Schulze M; Kalthoff H; Fändrich F; Ungefroren H
J Biol Chem; 2005 Sep; 280(39):33190-9. PubMed ID: 16051607
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein.
Yoshida T; Zhang Y; Rivera Rosado LA; Chen J; Khan T; Moon SY; Zhang B
Mol Cancer Ther; 2010 Jun; 9(6):1657-68. PubMed ID: 20515940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]